Thousands of women in the United States were implanted with transvaginal mesh with the promise that it would help correct their stress urinary incontinence or pelvic organ prolapse, conditions that occur due to the weakening of pelvic muscles. According to lawsuits filed by the national law firm of Parker Waichman LLP, however, transvaginal mesh implants can actually cause more damage to a woman’s internal organs. The video above discusses serious injuries commonly associated with the use of mesh, including erosion, organ perforation, painful sexual intercourse and chronic pain. Furthermore, some women implanted with the device may experience recurrent pelvic organ prolapse, which is when the organs of the pelvis bulge into the vagina.
Patient advocates and consumer watchdog groups have often criticized the fact that transvaginal mesh implants were put onto the market without clinical testing since they were approved through 510(k). Last September, an advisory group for the U.S. Food and Drug Administration (FDA) recommended that the mesh be reclassified from moderate to high risk, which would force manufacturers to conduct safety tests on the devices for approval. Last summer, the agency warned that complications associated with transvaginal mesh are “not rare” and that there is little evidence of their benefit over non-mesh methods for treating pelvic organ prolapse. The FDA has asked that 33 manufacturers conduct post-market safety tests on transvaginal mesh.